New preclinical research reveals CBD’s potential to address multiple pathways in diabetic heart disease, including inflammation and oxidative stress. However, the cbd diabetic heart disease preclinical evidence requires human clinical trials before any therapeutic recommendations can be made for patients with diabetes-related cardiovascular complications.